Dual-purpose drugs perk up sales

Published: 2010-06-23 07:00:00
Updated: 2010-06-23 07:00:00
Various combination therapies made up 13.6 percent of the domestic drug market in 2009, representing the fastest-growing segment of that market, according to Ubist data.

Daewoong’s Olmetec Plus tablets topped 46.7 billion won in sales last year, maintaining its first rank. Novartis’s Exforge t...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.